InvestorsHub Logo
Followers 29
Posts 2189
Boards Moderated 1
Alias Born 05/09/2013

Re: None

Tuesday, 06/30/2020 8:59:02 AM

Tuesday, June 30, 2020 8:59:02 AM

Post# of 32012
Looking good and I do think TreT is the short term golden goose, but Afrezza data will eventually catch on in the market. It probably will never become the SOC, but even garnering 1% of the market would be huge. Its a tool in a diabetics bag to help with time in range and lowering your H1AC levels, while being Ultra Rapid Acting Insulin with the fastest acting response to lowering glucose levels.

Between the $12.5M from UTHR, another $12.5M coming in Q4 and $11M from the exercising of warrants we are good for the next 12 months at a minimum with an additional $36M in cash. Also we have drastically reduced burn rate from $22M a quarter to $11M per quarter.

We get the 2nd compound Mike keeps alluding too and we are in awesome shape moving forward. I think $3 this year is a given and we might even see a $4-$5 number by year end. Not to mention short interest has declined from 47M shares to 30M, so shorts are getting out. I was hoping for an eventual short squeeze and a second compound announcement would achieve this objective. Disappointed that we are letting the shorts out to easily, but at least they are backing out. Dilution is not in the cards right now and if we hit $4-$5 I'd be fine with 10M shares raising another $40-$50 million.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News